Integrative Pharmacovigilance: Monitoring Adverse Events of Herbal, Nutraceutical and Conventional Therapies

Abstract

Integrative pharmacovigilance represents a vital methodology for monitoring adverse events (AEs) linked to both herbal nutraceuticals and conventional therapies. Given the increasing utilization of complementary and alternative medicines (CAMs), it is crucial to ensure the safety of these products. By employing integrated pharmacovigilance strategies for both herbal nutraceuticals and conventional therapies, AEs can be comprehensively captured, data analysed to identify potential safety signals and trends, and associated risks assessed. This methodology empowers healthcare professionals and regulatory agencies to make informed decisions, thereby enhancing patient safety and outcomes. Integrative pharmacovigilance promotes a holistic understanding of the intricate interactions between herbal nutraceuticals and conventional therapies, facilitating more effective risk management and mitigation. The adoption of this approach allows for improved monitoring and management of AEs, alleviating the burden on healthcare systems and benefiting public health. Successful integrative pharmacovigilance necessitates collaboration among various stakeholders, including regulatory agencies, healthcare professionals, and industry partners.